• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Down0.16% Nasdaq Down0.08%

    Targacept, Inc. (TRGT)

    2.77 Up 0.01(0.36%) Jul 2, 4:00PM EDT
    Add to Portfolio
    ProfileGet Profile for:
    Targacept, Inc.
    100 North Main Street
    Suite 1510
    Winston-Salem, NC 27101
    United States - Map
    Phone: 336-480-2100
    Fax: 336-480-2107
    Website: http://www.targacept.com

    Index Membership:N/A
    Full Time Employees:19

    Business Summary 

    Targacept, Inc., a biopharmaceutical company, engages in the development of neuronal nicotinic receptors (NNR) therapeutics for the treatment of nervous system and gastrointestinal/genitourinary diseases and disorders. Its product candidates include TC-6499 for the treatment of diabetic gastroparesis; and TC-5619 and TC-6987, which are novel small molecules that are selective for the a7 NNR. The company was founded in 1997 and is based in Winston-Salem, North Carolina.

    Key Statistics

    Company Websites 
    Home Page
    Search Yahoo! for:
    More on Targacept, Inc.

    Corporate Governance 
    Targacept, Inc.’s ISS Governance QuickScore as of Jul 1, 2014 is 6. The pillar scores are Audit: 1; Board: 3; Shareholder Rights: 8; Compensation: 5.
    Brought to you by Institutional Shareholder Services (ISS)

    Key Executives 
    Dr. Stephen A. H. Hill B.M. B.Ch. M.A. F.R.C.S., 57
    Chief Exec. Officer, Pres and Director
    Ms. Mauri K. Hodges CPA, C.C.P., 57
    Chief Financial Officer, Principal Accounting Officer, VP of Fin. & Admin. and Treasurer
    Mr. Patrick C. Rock J.D., 55
    Sr. VP, Gen. Counsel and Sec.
    Dr. Jessica S. Beaver Ph.D., R.A.C,
    Sr. Director of Regulatory Affairs and Quality Compliance
    Amounts are as of Dec 31, 2014 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
    Currency in USD.
    View Insiders